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In this study, we investigated the structural activity relationships (SARs) of ﬂavonoids with estro-
gen-related receptor c (ERRc) and its coactivator peroxisome proliferators-activated receptor c
coactivator-1a (PGC-1a). Isoﬂavones (genistein and daidzein) and ﬂavanones (naringenin and hes-
peretin) did not signiﬁcantly affect ERRc activity. Flavone apigenin and ﬂavonol kaempferol directly
suppressed the interaction between ERRc and PGC-1a functioning as inverse agonists. In contrast,
ﬂavone luteolin suppressed PGC-1a activity in part through promoting the degradation of PGC-1a
leading to suppressed ERRc activity. Therefore, these ﬂavones and ﬂavonols utilize alternative
mechanisms to inﬂuence the transcriptional activities of ERRc and PGC-1a.
Structured summary:
MINT-7297297, MINT-7297435: PGC-1 alpha NR2 (uniprotkb:Q9UBK2) binds (MI:0407) to ERR gamma
(uniprotkb:P62508) by surface plasmon resonance (MI:0107)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Flavonoids are natural polyphenolic products that can be found
in a variety of plants and fruits [1]. Flavonoids can be further
classiﬁed into ﬂavones (2-phenylchromen-4-one), ﬂavonols
(3-hydroxy-2-phenylchromen-4-one), ﬂavanones (2,3-dihydro-2-
phenylchromen-4-one), and isoﬂavones (3-phenylchromen-4-
one) (Fig. 1). Flavones such as apigenin and luteolin can be found
in celery and green pepper, while ﬂavanones such as naringenin
and hesperetin are abundant in citrus fruits. Tea is a good source
of ﬂavonols such as kaempferol and quercetin; whereas, soybean
is loaded with isoﬂavones such as genistein and daidzein. Since
many of these ﬂavonoids are anti-oxidants, high levels of dietary
consumption are believed to confer a multitude of health beneﬁts
including reducing oxidative damages [2].
The mechanisms of action behind certain beneﬁcial effects ex-
tend beyond just antioxidant activity. Estrogen receptors a and b
(ERa and ERb) are transcription factors that bind to speciﬁc hor-
mone response elements located near their target genes and regu-
late their expression in a ligand-dependent manner. Genistein and
other ﬂavonoids are phytoestrogens, i.e. they function as selective
estrogen receptor modulators (SERMs) [3]. It is hypothesized thatchemical Societies. Published by E
PGC-1a, peroxisome prolifer-
ural activity relationship
ong).these ﬂavonoids modulate the endogenous activities of estrogen
receptors to slow down or prevent the developments of breast
and ovarian cancers [4].
Estrogen-related receptors a and c (ERRa and ERRc) together
with their coactivator peroxisome proliferators-activated receptor
c coactivator-1a (PGC-1a) are key regulators of mitochondrial
function [5]. ERRs share high degrees of similarity in the DNA bind-
ing domain (DBD) with ERs. On the other hand, the ligand binding
domains (LBDs) of ERRs are divergent from that of ERs. Although
ERRs are constitutively active transcription factors, we previously
established that kaempferol can function as an ERRa and ERRc in-
verse agonist [6]. In this study, we investigated into the differential
abilities of ﬂavones, ﬂavonols, ﬂavanones, and isoﬂavones to
regulate the activities of ERRc and PGC-1a by reporter-
based assays in HeLa cells and direct interaction assay by surface
plasmon resonance.2. Materials and methods
2.1. Reagents
17b-Estradiol, 4-hydroxytamoxifen, daidzein, apigenin, and
genistein were obtained from Sigma. Hesperetin, kaempferol, lute-
olin, naringenin, and quercetin were purchased from shanxi Huike
Botanical Development Co., Ltd. DY-131 was obtained from Tocris.
BIAcore 3000 system, certiﬁed SA sensor chips, and amine coupling
reagents were obtained from BIAcore, Inc.lsevier B.V. All rights reserved.
Fig. 1. Chemical structures of ﬂavonoids. Structures of ﬂavones, ﬂavonols, ﬂavanones, and isoﬂavones are shown with the A-, B-, and C-rings indicated.
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A Gal4-DBD-PGC-1a fusion was cloned as described [7]. Trans-
fection of HeLa cells by expression and reporter vectors as well as
luciferase assays were performed as described [6]. All transfections
were performed at least three times with the mean and SEM of
these experiments shown in Figs. 2 and 4.
2.3. Interaction between ERRc and PGC-1a analyzed by surface
plasmon resonance assay
Human ERRc-LBD protein was expressed and puriﬁed as
described [6]. Interactions between ERRc-LBD and PGC-1a
coactivator peptides in the presence of various compounds
were analyzed using a BIAcore 3000 system. Biotinylated PGC-1a
peptides: EEPSLAKKAALAPAN (NR2 negative control); ENE-
ANLLAVLTETLD (NR1); EEPSLLKKLLLAPAN (NR2); and RPCSELLK-
YLTTNDD (NR3) were captured onto streptavidin immobilized
surface of SA chip in ﬂow cells 1, 2, 3, and 4, respectively. ERRc-
LBD incubated with various ligands in running buffer (50 mM Tris
pH 8.0, 150 mM NaCl, 1 mM MgCl2, 0.002% NP-40, 0.2 mM DTT)
were injected into ﬂow cells for 3 min at a ﬂow rate of 20 lL/min
at 25 C. Changes in resonance units (RU) were monitored simulta-
neously in all ﬂow cells. Surface was regenerated at the end of each
cycle by an injection of 0.05% SDS. Sensorgrams were generated byBIAcontrol software 4.1 using double-referencing to eliminate re-
sponses from the reference surface and buffer-only control. Spe-
ciﬁc changes in RU were generated with non-speciﬁc interaction
between LBD and NR2 negative control mutant peptide deducted.
2.4. Western blot analysis
Cells were lysed using RIPA reagent (Shanghai Shenneng)
according to the manufacturer’s protocol and protein extracts were
analyzed by 10% SDS–PAGE and blotted onto PVDF membrane.
Membranes were incubated with rabbit anti-human-PGC-1a anti-
body generated in house or mouse anti-b-actin antibody (Boster)
followed by horseradish peroxidase-conjugated secondary anti-
body (Amersham) and developed with BeyoECL Plus reagent
(Beyotime).3. Results
3.1. Effects of ﬂavonoids on ERb and ERRc
We aimed to study the structural activity relationship (SAR) of
ﬂavonoids with ERRc. We ﬁrst conﬁrmed the abilities of these
ﬂavonoids to act as ERb agonists. By measuring the activity of a re-
porter gene luciferase under the control of a Gal4-DBD-ERb-LBD
Fig. 2. Effects of ﬂavonoids on the activities of ERb and estrogen-related receptor c (ERRc). (A) HeLa cells were transfected with an expression plasmid of Gal4-DBD-ERb-LBD
together with a luciferase reporter and a control Renilla luciferase plasmid. About 10 nM 17b-estradiol as a positive control or different ﬂavonoids at 5 lMwere added for 24 h
before luciferase assays. Fold induction by compounds were calculated and shown compared to dimethyl sulfoxide (DMSO) as a vehicle. (B) HeLa cells were transfected with
expression plasmids of Gal4-DBD control or Gal4-DBD-ERRc-LBD with or without pcDNA-peroxisome proliferators-activated receptor c coactivator-1a (PGC-1a) together
with a luciferase reporter and a control Renilla luciferase plasmid. DMSO or 10 lM 4-hydroxytamoxifen (4-OHT) was added and assays performed as in (A). (C) Transfection
were performed as in (B) with different ﬂavonoids (1, 5, and 25 lM); % activity indicates the normalized activities of ERRc under the inﬂuences of ﬂavonoids compared to
DMSO control set at 100%. (A–C) Results represent mean ± S.E.M. **P < 0.01.
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nists in HeLa cells except for hesperetin (Fig. 2A).
The activity of ERRc is strongly enhanced in the presence of co-
expressed PGC-1a while an inverse agonist 4-hydroxytamoxifen
suppresses this activity (Fig. 2B) [8]. We then examined the effects
of these ﬂavonoids on ERRc in this system and found that isoﬂav-
one genistein did not signiﬁcantly affect whereas daidzein very
modestly enhanced ERRc activity (Fig. 2C). Flavanones naringenin
and hesperetin did not show any dose-dependent effects (Fig. 2C).
In contrast, ﬂavone apigenin and ﬂavonol kaempferol suppressed
ERRc activity in dose-dependent manners with kaempferol being
more potent (Fig. 2C). Flavone luteolin fully and ﬂavonol quercetin
partially suppressed ERRc activity at 25 lM (Fig. 2C). We then
asked if the abilities of these ﬂavonoids to suppress ERRc activity
are due to reduced cellular viabilities. Total cellular level of ATP
is reﬂective of viability. We measured total cellular ATP content
upon ﬂavonoid treatments and found that only quercetin partially
reduced viability correlating to its ability to suppress ERRc activity
(Supplementary Fig. S1). This result also implies that the abilities of
other ﬂavonoids to function as ERRc activity modulators rely on
mechanisms other than reducing viability.
3.2. Apigenin interferes with the interaction between ERRc and PGC-1a
ERRc activity is dependent on its interaction with PGC-1a
through the receptor interacting (NR) motifs of PGC-1a with astrong preference for NR2 over NR1 and NR3 (Fig. 3A). We then
examined this in vitro interaction in the presence of daidzein, api-
genin, luteolin, and kaempferol. Among these modulators, we pre-
viously demonstrated that kaempferol functions as an ERRc
inverse agonist by directly blocking this interaction measured
by a surface plasmon resonance based assay [6]. Using this assay,
we found that daidzein and luteolin failed to enhance or interfere
with this interaction compared to positive controls with DY-131
as an agonist and 4-hydroxytamoxifen as an inverse agonist
(Fig. 3B) [8,9]. On the other hand, apigenin dose-dependent sup-
pressed this interaction apparently functioning as an ERRc in-
verse agonist (Fig. 3C). Genistein, naringenin, and hesperetin did
not affect the interaction between ERRc and PGC-1a (data not
shown).
3.3. Luteolin suppresses the transcriptional activating function within
PGC-1a
Since luteolin modulated ERRc activity without affecting its
interaction with PGC-1a, we examined if it would directly affect
the transcriptional activating function within PGC-1a. When fused
to a Gal4-DBD, PGC-1a displays a strong transcriptional activating
function on a reporter under the control of Gal4-DBD [7]. We found
that luteolin affected PGC-1a activity mirroring its modulation on
ERRc activity (Fig. 4A). We next examined if luteolin suppressed
PGC-1a activity by alerting its protein stability. We found that
Fig. 3. Apigenin directly blocks the interaction between ERRc and PGC-1a. (A) 125 nM of puriﬁed ERRc-LBD was tested for its interaction with NR1, NR2, and NR3 motifs as
described [6]. (B) DMSO, 1 lM 4-OHT, 5 lM DY-131, 25 lM daidzein, or 25 lM luteolin was incubated with 50 nM ERRc-LBD for 1 hr before interaction analysis with NR2 as
in (A). (C) Different doses of apigenin were tested as in (B).
Fig. 4. Effects of ﬂavonoids on the activity of PGC-1a. (A) HeLa cells were transfected with an expression plasmid of Gal4-DBD or Gal4-DBD-PGC-1a together with a luciferase
reporter and a control Renilla luciferase plasmid. DMSO or 1, 5, and 25 lM luteolin were added for 24 h; % activity indicates the normalized activities of PGC-1a compared to
DMSO control set at 100%. (B) HeLa cell extracts pre-treated with DMSO or 25 lM luteolin was probed with anti-PGC-1a or b-actin antibodies for Western analysis. PGC-1a
protein levels normalized to b-actin from three independent experiments were quantiﬁed. Results represent mean ± S.E.M. **P < 0.01.
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analysis (Fig. 4B).
4. Discussion
Flavonoids share a common core phenylchromen-4-one struc-
ture consists of A-, B-, and C-rings (Fig. 1). Both ﬂavones and iso-
ﬂavones function as ERb agonists, suggesting that the position of
the B-ring is not critical (Fig. 2A). However, substitutions on the
B-ring play a key role. Although apigenin, luteolin, kaempferol,
and quercetin function as ERb agonists, luteolin and quercetin with
additional hydroxyl groups at the 3’-position of the B-ring are
slightly less potent (Fig. 2A). Importantly, hesperetin with a meth-
oxy group at the 40-position of the B-ring instead of a hydroxyl
group as in naringenin, fails to function as an ERb agonist (Fig. 2A).
Several ﬂavonoids, speciﬁcally, isoﬂavones genistein, daidzein,
biochanin A and ﬂavone 6,30,40-trihydroxyﬂavone were reported
to function as ERRa and ERRc agonists based on virtual ligand
screening and reporter-based assays [10]. However, in this study
we did not observe any effect of genistein on ERRc by in vitro puri-
ﬁed ERRc-LBD interaction with PGC-1a NR2 motif and luciferase
reporter assays (Figs. 2 and 3). Independently, another group also
failed to reproduce these effects [11]. On the other hand, we iden-
tiﬁed in this and a previous study that apigenin and kaempferol
block the interaction between ERRc and PGC-1a and suppress
the expression of ERRc target gene pyruvate dehydrogenase kinase
4 (PDK4) (Supplementary Fig. S2) as bone ﬁde ERRc inverse ago-
nists (Fig. 3) [6].Based on these results, we conclude that isoﬂavones with their
B-rings at position 3 of the C-ring do not block the in vitro ERRc
interaction with PGC-1a. On the contrary, certain ﬂavones and
ﬂavonols such as apigenin and kaempferol with their B-rings at po-
sition 2 are capable of interferingwith this interaction.While apige-
nin and kaempferol function as ERRc inverse agonists, luteolin and
quercetin do not affect the ERRc interaction with PGC-1a (Fig. 3).
Comparing the structures among these ﬂavonoids suggests that a
hydroxyl group at position 3 of the C-ring can be accepted but a hy-
droxyl group at position 30 of the B-ring is not tolerable (Fig. 1).
Although ﬂavanones such as naringenin and hesperetin have their
B-rings at position 2 of the C-rings, they fail to affect the interaction
due to their 2,3-dihydro substitutions on the C-rings.
Disrupting the interaction between ERRc and PGC-1a is not the
only mechanism by which certain ﬂavones and ﬂavonols function
to suppress ERRc activity. Despite failing to block the ERRc interac-
tion with PGC-1a (Fig. 3), luteolin down-modulates ERRc activity
by suppressing the transcriptional activating function within
PGC-1a in part through reducing its protein level (Fig. 4). PGC-1a
is subjected to degradation by the ubiquitin-proteasome pathway
[12] which is regulated by glycogen synthase kinase 3b (GSK3b)
and p38MAPK [13]. Luteolin may affect the activities of these ki-
nases or the expression of E3 ubiquitin ligases to reduce PGC-1a
protein level through promoting its degradation. Since luteolin is
more potent in suppressing PGC-1a activity than reducing its pro-
tein level (Fig. 4), luteolin may also inﬂuence other post-transla-
tional modiﬁcations of PGC-1a to affect its activity [14]. In all,
we established in this study a SAR between ﬂavonoids and ERRc
26 Z. Huang et al. / FEBS Letters 584 (2010) 22–26activity; namely, certain ﬂavones and ﬂavonols utilize alternative
mechanisms to suppress ERRc activity through either disrupting
the interaction between ERRc and PGC-1a or suppressing PGC-
1a activity through promoting PGC-1a protein degradation. These
alternative mechanisms may be further subjected to cell type spe-
ciﬁc regulation; thus, more extensive analysis of the inﬂuences of
ﬂavonoids on metabolic regulation mediated by ERRc and PGC-
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